Clinical study for community based prevention and control strategy of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed populatio

Phase 1

Recruiting

• Conditions: ovel Coronavirus Pneumonia (COVID-19)

• Registration Number: ITMCTR2000002974
• Lead Sponsor: Hubei Provincial Hospital of TCM

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Conforming to the diagnostic criteria for the above close contacts;
2. Aged between 18 and 65 years old;
3. Signing the generalized informed consent form. (The intervention objects is incorporated in the clinical study as desired).

Exclusion Criteria

1. Severe or critically severe patients;
2. Clear evidence of bacterial infection;
3. Patients with severe primary diseases such as heart, kidney, lung, endocrine, blood, metabolism, and gastrointestinal tract, etc., may affect participation in the trial or may affect the outcome of the study by the judgment of the researcher;
4. Patients who have a family history of mental illness or have had a mental illness;
5. Patients who are allergic constitution or allergy to multiple drug;
6. pregnant or lactating women.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of onset at home / designated isolation population who progressed to designated isolation treatment or were diagnosed with novel coronavirus-infected pneumonia;days of onset at home / designated isolation population who progressed to designated isolation treatment or were diagnosed with novel coronavirus-infected pneumonia;

Secondary Outcome Measures

Name	Time	Method
body temperature;Symptom Scale;